LDLRAP1 and neoplasm: The heterozygous mouse showed tumors that exhibited mutations in the remaining Arh1 allele that altered its enzymatic activity, so that it was not effective as an ADP-ribosyl-arginine hydrolase, thus the tumor was acting as an Arh1 KO.